Φορτώνει......
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis
OBJECTIVE: To characterize changes in myeloid and lymphoid innate immune cells in patients with relapsing-remitting multiple sclerosis (MS) during a 6-month follow-up after alemtuzumab treatment. METHODS: Circulating innate immune cells including myeloid cells and innate lymphoid cells (ILCs) were a...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063395/ https://ncbi.nlm.nih.gov/pubmed/27766281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000289 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|